InMed Pharmaceuticals Inc

10:30 AM - 10:45 AM (EDT), Wednesday, October 23, 2019 ・ 2nd Floor
InMed is a biopharmaceutical company that specializes in the discovery and development of novel, cannabinoid-based therapeutics for the treatment of diseases with high unmet medical need.

InMed employs a highly scientific approach to designing and developing medicines, which will help unlock the full potential of cannabinoid pharmaceuticals. One proprietary technology is our bioinformatics platform, which uses a computer-based drug candidate selection process to reach high-probability conclusions from massive, publicly available databases together with an internal library of cannabinoid drug information.

InMed is also developing a robust, high-yield, microbial-based biosynthesis process designed to enable the manufacturing of the multitude of cannabinoids (100+) found from natural sources, with significant cost reductions and increased manufacturing capabilities.
Ticker:
IN
Exchange:
TSX
Company Type:
Company Website:
Company HQ State:
British Columbia
Company HQ Country:
Canada
Year Founded:
2014
Main Therapeutic Focus:
Lead Product in Development:
INM-755
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided